Laura Rosiñol Selected Research

Laura Rosiñol Research Topics

Disease

85	Multiple Myeloma 06/2022 - 05/2002
11	Neoplasms (Cancer) 01/2022 - 07/2004
9	Disease Progression 01/2021 - 01/2005
8	Monoclonal Gammopathy of Undetermined Significance 10/2021 - 05/2002
6	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 01/2018
6	Plasmacytoma 01/2022 - 05/2004
6	Immunoglobulin Light-chain Amyloidosis 12/2021 - 02/2008
6	Residual Neoplasm 09/2021 - 01/2012
6	Smoldering Multiple Myeloma 01/2018 - 09/2005
5	Paraproteinemias (Monoclonal Gammopathy) 04/2021 - 03/2003
4	Infections 01/2022 - 01/2005
4	Amyloidosis 12/2017 - 10/2012
4	Pathologic Complete Response 01/2014 - 12/2009
3	Lymphoma (Lymphomas) 01/2021 - 01/2012
3	Peripheral Nervous System Diseases (PNS Diseases) 09/2013 - 08/2004
2	Thrombocytopenia (Thrombopenia) 02/2022 - 01/2016
2	Pneumonia (Pneumonitis) 02/2022 - 01/2016
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2022 - 01/2020
2	Neutropenia 02/2022 - 08/2016
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 04/2021 - 04/2003
2	Bronchiolitis Obliterans Syndrome 02/2021 - 11/2008
2	Fever (Fevers) 01/2020 - 01/2020
2	Crohn Disease (Crohn's Disease) 10/2017 - 01/2016
2	Renal Insufficiency (Renal Failure) 01/2005 - 08/2004
1	COVID-19 02/2022
1	Heart Failure 02/2022
1	Pancytopenia 02/2022
1	Circulating Neoplastic Cells 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 12/2021
1	Thrombotic Microangiopathies 01/2021
1	Genomic Instability 01/2021
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2021
1	Inflammation (Inflammations) 12/2020
1	Sepsis (Septicemia) 01/2020

Drug/Important Bio-Agent (IBA)

22	Dexamethasone (Maxidex)FDA LinkGeneric 06/2022 - 01/2005
19	Bortezomib (Velcade)FDA Link 12/2021 - 01/2005
14	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2003
13	Lenalidomide (CC 5013)FDA Link 02/2022 - 08/2013
11	Thalidomide (Thalomid)FDA Link 01/2021 - 03/2003
9	Melphalan (Alkeran)FDA LinkGeneric 11/2021 - 01/2005
8	carfilzomibIBA 06/2022 - 01/2015
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2012
5	Proteasome InhibitorsIBA 02/2022 - 01/2005
5	Prednisone (Sone)FDA LinkGeneric 10/2018 - 11/2010
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 08/2012
4	Pharmaceutical PreparationsIBA 12/2020 - 07/2004
3	Nerve Growth Factor (NGF)IBA 01/2021 - 10/2020
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 01/2005
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 08/2004
3	Oligoclonal BandsIBA 08/2017 - 12/2009
3	Immunoglobulins (Immunoglobulin)IBA 07/2012 - 01/2011
2	Monoclonal AntibodiesIBA 06/2022 - 06/2012
2	pomalidomideIBA 02/2022 - 05/2019
2	daratumumabIBA 01/2022 - 01/2020
2	ParaproteinsIBA 01/2022 - 05/2019
2	Immunoglobulin M (IgM)IBA 04/2021 - 12/2017
2	Biological ProductsIBA 01/2021 - 01/2020
2	Immunomodulating AgentsIBA 12/2020 - 10/2017
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020 - 02/2008
2	Immunoglobulin G (IgG)IBA 10/2018 - 11/2010
2	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 06/2018 - 01/2012
2	MicroRNAs (MicroRNA)IBA 01/2015 - 07/2012
2	CytokinesIBA 09/2011 - 05/2002
2	Cytotoxins (Cytolysins)IBA 01/2011 - 01/2005
2	Busulfan (Busulfex)FDA Link 11/2010 - 12/2007
2	Diphosphonates (Bisphosphonates)IBA 03/2010 - 10/2008
1	isatuximabIBA 06/2022
1	melflufenIBA 02/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Immunoglobulin A (IgA)IBA 01/2022
1	Serum AlbuminIBA 01/2022
1	B-Cell Maturation AntigenIBA 12/2021
1	Chimeric Antigen ReceptorsIBA 12/2021
1	Amyloid (Amyloid Fibrils)IBA 12/2021
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 12/2021
1	Etoposide (VP 16)FDA LinkGeneric 01/2021
1	Clarithromycin (Biaxin)FDA LinkGeneric 01/2021
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	cadherin 5IBA 12/2020
1	NectinsIBA 01/2020
1	FluoroquinolonesIBA 01/2020
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2020
1	poliovirus receptorIBA 01/2020

Therapy/Procedure

38	Therapeutics 02/2022 - 07/2004
31	Stem Cell Transplantation 12/2021 - 10/2007
8	Transplantation 01/2022 - 11/2008
8	Hematopoietic Stem Cell Transplantation 01/2021 - 12/2009
4	Autologous Transplantation 07/2013 - 02/2008
4	Drug Therapy (Chemotherapy) 07/2013 - 12/2005
2	Patient Readmission 01/2020 - 01/2020
2	Aftercare (After-Treatment) 12/2017 - 11/2016
2	Induction Chemotherapy 01/2011 - 11/2010
1	Kidney Transplantation 11/2021
1	Hemodilution 09/2021
1	Ambulatory Care (Outpatient Care) 01/2020
1	Antibiotic Prophylaxis 01/2020